← Back to Browse
ProductDiagnostic Tests

Rapid SARS-CoV-2 Antigen Test Card

Xiamen, Fujian, China

A lateral flow immunoassay test card intended for qualitative detection of SARS-CoV-2 nucleocapsid protein with FDA EUA authorization. The rapid test provides quick diagnostic results for COVID-19 detection.

Manufactured by

Xiamen, Fujian, China

Specializes in developing and manufacturing in vitro diagnostic kits, including point of care and immunoassay products for global markets. Operates a 12,500 square meter facility under ISO 13485:2016 and GMP guidelines, with products approved by China NMPA and exported to over 70 countries. Focuses on diagnostic rapid tests and offers customized solutions alongside comprehensive technical support services.

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
75 relevant products
2United States
10 relevant products
3Germany
4 relevant products
🔒

13 more sourcing countries available

Get free access to all sourcing countries identified for this product.

See all countries →

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 113 closest product alternatives

113 products

110 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products